Researchers developed the for predicting death and complications after percutaneous coronary intervention (PCI). (European Heart Journal)
A single bolus of boosted patency of the infarct-related artery and reduced infarct size in some heart attack patients. (Circulation: Cardiovascular Interventions)
produced a hemostat that directly stimulates blood clotting, and when tested, stopped bleeding within 9 minutes in people on heparin who underwent cardiac catheterization. (PNAS)
Is it worth it trying to combine left atrial appendage occlusion with in one go? (JACC: Cardiovascular Interventions)
For acute ischemic stroke, seemed well tolerated in people treated with alteplase with or without mechanical thrombectomy in phase Ib/IIa data. (Lancet Neurology)
The American College of Cardiology is still asking Congress to to the Medicare Physician Fee Schedule currently in effect.
after brain death of organ donors were short-lived and had little bearing on graft survival of donated hearts. (JACC: Heart Failure)
Patients with acute pericarditis with concomitant myocardial involvement had fewer recurrences if they were given , a retrospective study showed. (Heart)
Bempedoic acid (Nexletol) cut down on in a prespecified analysis of the CLEAR Outcomes trial. (JAMA Cardiology)
Real-world mitral valve transcatheter edge-to-edge repair for functional mitral regurgitation was often performed in and who did go on to suffer worse outcomes. (Journal of the American College of Cardiology)
were associated with higher mortality in people with cardiogenic shock, a large international registry showed. (Journal of the American Heart Association)
Black women who reported experiencing some aspects of tended to be at higher risk of coronary heart disease. (Circulation)
People allowed to look at their were more likely to improve their medication adherence and lifestyle choices. (European Journal of Preventive Cardiology)
Does predict poor cardiovascular health in adulthood? (Circulation: Cardiovascular Quality and Outcomes)
Dutch study finds that to prevent heart and kidney disease events is likely cost-effective. (eClinicalMedicine)
There has been a drop in late cardiac toxic effects associated with , as contemporary protocols favoring less radiation therapy and more pharmacologic cardioprotection seem to offset the greater use of doxorubicin. (JAMA Network Open)
Scientists believe that a mitochondrial protein could be a good therapeutic target for . (Science Advances)